M. Annoussamy

1.1k total citations
27 papers, 297 citations indexed

About

M. Annoussamy is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Annoussamy has authored 27 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Genetics and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Annoussamy's work include Muscle Physiology and Disorders (19 papers), Neurogenetic and Muscular Disorders Research (13 papers) and Cardiomyopathy and Myosin Studies (12 papers). M. Annoussamy is often cited by papers focused on Muscle Physiology and Disorders (19 papers), Neurogenetic and Muscular Disorders Research (13 papers) and Cardiomyopathy and Myosin Studies (12 papers). M. Annoussamy collaborates with scholars based in France, Belgium and United Kingdom. M. Annoussamy's co-authors include Laurent Servais, Teresa Gidaro, Jean‐Yves Hogrel, A. Moraux, Aurore Daron, Thomas Voit, Pierre G. Carlier, A. Seferian, David Vissière and Inge Cuppen and has published in prestigious journals such as PLoS ONE, Neurology and Muscle & Nerve.

In The Last Decade

M. Annoussamy

26 papers receiving 293 citations

Peers

M. Annoussamy
I. Rybalsky United States
M. Annoussamy
Citations per year, relative to M. Annoussamy M. Annoussamy (= 1×) peers I. Rybalsky

Countries citing papers authored by M. Annoussamy

Since Specialization
Citations

This map shows the geographic impact of M. Annoussamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Annoussamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Annoussamy more than expected).

Fields of papers citing papers by M. Annoussamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Annoussamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Annoussamy. The network helps show where M. Annoussamy may publish in the future.

Co-authorship network of co-authors of M. Annoussamy

This figure shows the co-authorship network connecting the top 25 collaborators of M. Annoussamy. A scholar is included among the top collaborators of M. Annoussamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Annoussamy. M. Annoussamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reyngoudt, Harmen, Pierre‐Yves Baudin, Ericky Caldas de Almeida Araújo, et al.. (2024). Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy. Journal of Cachexia Sarcopenia and Muscle. 15(3). 1108–1120. 9 indexed citations
3.
Boulanger, Bruno, M. Annoussamy, A. Seferian, et al.. (2021). Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy. Orphanet Journal of Rare Diseases. 16(1). 3–3. 21 indexed citations
4.
Daron, Aurore, O. Schneider, Fabian Dal Farra, et al.. (2021). Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environment. Orphanet Journal of Rare Diseases. 16(1). 318–318. 14 indexed citations
5.
Annoussamy, M., et al.. (2021). OUTCOME MEASURES. Neuromuscular Disorders. 31. S148–S148. 1 indexed citations
6.
Lilien, C., Harmen Reyngoudt, A. Seferian, et al.. (2021). Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy. Annals of Clinical and Translational Neurology. 8(10). 1938–1950. 10 indexed citations
7.
Gidaro, Teresa, M. Annoussamy, John Vissing, et al.. (2021). Home‐based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy. Muscle & Nerve. 65(2). 237–242. 12 indexed citations
8.
Daron, Aurore, O. Schneider, Fabian Dal Farra, et al.. (2021). DMD/BMD – OUTCOME MEASURES. Neuromuscular Disorders. 31. S86–S87. 1 indexed citations
9.
Gangfuß, Andrea, et al.. (2020). Diagnosing X-linked Myotubular Myopathy – A German 20-year Follow Up Experience. Journal of Neuromuscular Diseases. 8(1). 79–90. 10 indexed citations
10.
Gidaro, Teresa, Harmen Reyngoudt, Anthony Béhin, et al.. (2019). Quantitative nuclear magnetic resonance imaging detects subclinical changes over 1 year in skeletal muscle of GNE myopathy. Journal of Neurology. 267(1). 228–238. 12 indexed citations
11.
Mercuri, Eugenio, Giovanni Baranello, Janbernd Kirschner, et al.. (2019). O.41Sunfish part 1: 18-month safety and exploratory outcomes of risdiplam (RG7916) treatment in patients with type 2 or 3 spinal muscular atrophy. Neuromuscular Disorders. 29. S208–S208. 3 indexed citations
12.
Annoussamy, M., Willem De Ridder, C. Lilien, et al.. (2019). P.107Clinical changes over time in patients with centronuclear myopathy due to mutations in DNM2 gene enrolled in a European prospective natural history study. Neuromuscular Disorders. 29. S79–S80. 1 indexed citations
13.
Seferian, A., A. Moraux, Teresa Gidaro, et al.. (2017). Innovative home activity monitoring in non-ambulant patients with spinal muscular atrophy: a multicenter observational trial. Neuromuscular Disorders. 27. S225–S225. 1 indexed citations
14.
Gidaro, Teresa, Laurent Servais, Stefano C. Previtali, et al.. (2017). Rimeporide: safety, tolerability and pharmacokinetic results from a phase Ib study in DMD boys as well as exploratory biomarkers. Neuromuscular Disorders. 27. S215–S216. 3 indexed citations
15.
Chabanon, A., M. Annoussamy, Aurore Daron, et al.. (2017). Longitudinal data of the European prospective natural history study of patients with type 2 and 3 spinal muscular atrophy. Neuromuscular Disorders. 27. S134–S134. 3 indexed citations
16.
Moing, Anne‐Gaëlle Le, A. Seferian, A. Moraux, et al.. (2016). A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment. PLoS ONE. 11(6). e0156696–e0156696. 35 indexed citations
17.
Chabanon, A., Yann Péréon, Aurore Daron, et al.. (2016). Baseline data from a European prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy – NatHis-SMA. Neuromuscular Disorders. 26. S103–S103. 2 indexed citations
18.
Annoussamy, M., C. Lilien, Teresa Gidaro, et al.. (2016). Baseline data from patients with myotubular myopathy enrolled in a European prospective and longitudinal natural history study. Neuromuscular Disorders. 26. S116–S117. 1 indexed citations
19.
Annoussamy, M., C. Lilien, G. Ollivier, et al.. (2015). Natural history and functional status of patients with myotubular myopathy enrolled in a prospective and longitudinal study. Neuromuscular Disorders. 25. S274–S274. 1 indexed citations
20.
Moraux, A., et al.. (2014). T.P.9. Neuromuscular Disorders. 24(9-10). 862–863. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026